Potential Use of 3D CORAGRAF-Loaded PDGF-BB in PLGA Microsphere Seeded Mesenchymal Stromal Cells in Enhancing the Repair of Calvaria Critical-Size Bone Defect in Rat Model

• Published in: Marine drugs 2022-08, Vol.20 (9), p.561
• Main Authors: Mohan, Saktiswaren, Karunanithi, Puvanan, Raman Murali, Malliga, Anwar Ayob, Khairul, Megala, Jayaraman, Genasan, Krishnamurithy, Kamarul, Tunku, Balaji Raghavendran, Hanumantha Rao
• Format: Article
• Language: English
• Subjects: Animal models; Biocompatibility; Biomechanics; Bone growth; Bone imaging; Bone marrow; Bones; Calvaria; Cell adhesion; Cell growth; Cell proliferation; Collagen; Commercialization; Computed tomography; coral; Defects; Drug delivery systems; Growth factors; Histology; Marketing; Mesenchymal stem cells; Mesenchyme; micro-CT; microsphere; platelet-derived growth factor; Platelet-derived growth factor BB; Polylactide-co-glycolide; Proliferation; Regeneration; Regeneration (biological); Regeneration (physiology); Rodents; Skull; Stromal cells; Tissue engineering
• ISSN: 1660-3397; 1660-3397
• DOI: 10.3390/md20090561

Our previous study evidenced that the 3D CORAGRAF loaded with PLGA microsphere constitutes PDGF-BB can support cell attachment and proliferation and can induce an osteogenic commitment of mesenchymal stromal cells in the in vitro condition. However, how this construct can perform in pathophysiological conditions in terms of repairing critical bone defects is yet to be understood. A study was therefore conducted to investigate the regeneration potential of calvaria critical-size defects using CORAGRAF + PLGA with PDGF-BB + mesenchymal stromal cells (MSCs) in a rat model. A 5 mm critical bone defect was created on calvaria of 40 male Sprague-Dawley rats. CORAGRAF incorporated either with or without PDGF-BB and seeded with rat bone-marrow-derived MSCs was implanted at the defect region. The bone regeneration potential of implanted constructs was assessed using micro-CT imaging and histological staining in weeks 4 and 8. The micro-CT images indicated a significant closure of defects in the cranial bone of the rats treated with 3D CORAGRAF + PLGA with PDGF-BB + MSCs on week 4 and 8 post-implantation. This finding, further supported with the histology outcome where the rat cranial defect treated with CORAGRAF + PLGA with PDGF-BB + MSCs indicated neo-bony ingrowth with organized and mature bone-like morphology as compared with other groups. The previous in vitro results substantiated with our pre-clinical findings demonstrate that the combination of CORAGRAF + PLGA with PDGF-BB + MSCs could be an ideal construct to support bone regeneration in critical bone defects. Hence, this construct can be further investigated for its safety and efficacy in large animal models, or it can be skipped to human trial prior for commercialization.